NASDAQ:MASI

Masimo - MASI Stock Forecast, Price & News

$141.16

-1.26 (-0.88%)

(As of 09/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $140.95
▼
$146.57
50-Day Range: $138.82
▼
$169.38
52-Week Range: $112.07
▼
$305.21

Volume: 402,929 shs
Average Volume: 915,437 shs
Market Capitalization: $7.42 billion

P/E Ratio: 42.52
Dividend Yield: N/A
Price Target: $194.50

Masimo MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.71 Rating Score
Upside/Downside: 37.8% Upside
$194.50 Price Target
Short Interest: Healthy
6.83% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.86
Upright™ Environmental Score
News Sentiment: 0.75
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 13.26%
From $4.45 to $5.04 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.85 out of 5 stars

Medical Sector

48th out of 1,093 stocks

Electromedical Equipment Industry

2nd out of 23 stocks

4.4

Analyst's Opinion

Consensus Rating
Masimo has received a consensus rating of Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $194.50, Masimo has a forecasted upside of 37.8% from its current price of $141.16.
Amount of Analyst Coverage
Masimo has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
6.83% of the float of Masimo has been sold short.
Short Interest Ratio / Days to Cover
Masimo has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Masimo has recently decreased by 4.64%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Masimo does not currently pay a dividend.
Dividend Growth
Masimo does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Masimo has received a 61.97% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "ECG monitors" product. See details.
Environmental Sustainability
The Environmental Impact score for Masimo is -0.86.

1.5

News and Social Media Coverage

News Sentiment
Masimo has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Masimo this week, compared to 6 articles on an average week.
Search Interest
Only 1 people have searched for MASI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
Only 5 people have added Masimo to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Masimo insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 9.70% of the stock of Masimo is held by insiders.
Percentage Held by Institutions
93.31% of the stock of Masimo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Masimo are expected to grow by 13.26% in the coming year, from $4.45 to $5.04 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Masimo is 42.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.51.
Price to Earnings Ratio vs. Sector
The P/E ratio of Masimo is 42.52, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 122.12.
Price to Book Value per Share Ratio
Masimo has a P/B Ratio of 5.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Masimo (NASDAQ:MASI) Stock

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Stock News Headlines

September 30, 2022 | bloomberg.com

Racial Bias in Pulse Oximeter Accuracy Becomes Inventor Focus - Bloomberg

September 27, 2022 | finance.yahoo.com

Global Nano Biosensors Market Size to reach USD 23.4 Bn by 2030 | CAGR 7.90%: Spherical Insights & Consulting - Yahoo Finance

September 21, 2022 | benzinga.com

Global Pulse Oximeters Market Report to 2031 - Featuring Masimo, Meditech Equipment, Medtronic and Nonin - Benzinga

September 21, 2022 | finance.yahoo.com

Masimo (NASDAQ:MASI) shareholders notch a 12% CAGR over 5 years, yet earnings have been shrinking

September 19, 2022 | businesswire.com

Masimo Appoints New Leader for Consumer Division - Business Wire

September 19, 2022 | finance.yahoo.com

Masimo Appoints New Leader for Consumer Division

September 14, 2022 | benzinga.com

Masimo (NASDAQ:MASI) – Where Masimo Stands With Analysts - Benzinga

September 14, 2022 | markets.businessinsider.com

Where Masimo Stands With Analysts

September 13, 2022 | americanbankingnews.com

Masimo (NASDAQ:MASI) Releases Q3 2022 Earnings Guidance

September 12, 2022 | businesswire.com

Global Remote Patient Monitoring System (Vital Sign Monitors, Specialized Monitors) Market Trends/Analysis Report 2022-2030 - ResearchAndMarkets.com - Business Wire

September 9, 2022 | businesswire.com

Remote Patient Monitoring Devices Thematic Research Report 2022 - ResearchAndMarkets.com - Business Wire

September 7, 2022 | fortune.com

Masimo Corporation | 2022 Best Workplaces in Manufacturing and Production - Fortune

September 6, 2022 | nasdaq.com

When Should You Buy Masimo Corporation (NASDAQ:MASI)? - Nasdaq

September 4, 2022 | globenewswire.com

Capnography Equipment Market to Surpass USD 930.45 Billion by 2028 | In Depth Analysis by Share, Demand, Trends, Forecast - GlobeNewswire

August 30, 2022 | finance.yahoo.com

Keltic Canada Development Celebrates Groundbreaking to Kick Off Construction of New Masimo Vancouver Facility

August 30, 2022 | businesswire.com

Keltic Canada Development Celebrates Groundbreaking to Kick Off Construction of New Masimo Vancouver Facility - Business Wire

August 29, 2022 | businesswire.com

Global Pulse Oximeter Market Research Report 2022: Increase in the Prevalence of Respiratory Diseases and Other Target Diseases Driving Growth - ResearchAndMarkets.com - Business Wire

August 25, 2022 | benzinga.com

Capnography Equipment Market Revenue to Cross US$ 716.38 million, Globally, by 2028 to Growing at 7.1% CAGR | Exclusive Report by The Insight Partners

August 21, 2022 | barrons.com

New Zealand All Out For 212 In 2nd West Indies ODI - Barron's

August 20, 2022 | barrons.com

New York Times and Masimo Stock See Action From Activist Investors - Barron's

August 19, 2022 | finance.yahoo.com

Wearable Pulse Oximeter Market to Reach $952.43 Million by 2027 - Yahoo Finance

August 18, 2022 | finance.yahoo.com

Masimo Corporation: Activist Investor Politan Takes 9% Stake in Masimo; No Change to FVE; Shares Fairly Valued

August 18, 2022 | reuters.com

Koffey's Politan takes 9% stake in Masimo, to push for change

August 16, 2022 | cnbc.com

Stocks making the biggest moves midday: Walmart, Bed Bath & Beyond, Zoom, Ally and more - CNBC

August 16, 2022 | reuters.com

Activist investor Politan Capital reports 8.4% stake in Masimo Corp

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter.

MASI Company Calendar

Last Earnings: 8/09/2022
Today: 9/30/2022
Next Earnings (Estimated): 10/25/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electromedical equipment
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NASDAQ:MASI
CUSIP: 57479510
CIK: 937556
Web: www.masimo.com
Phone: (949) 297-7000
Fax: 949-297-7001
Employees: 6,200
Year Founded: 1989

Price Target and Rating

Average Stock Price Forecast: $194.50
High Stock Price Forecast: $295.00
Low Stock Price Forecast: $150.00
Forecasted Upside/Downside: +37.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.71
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): $3.32
Trailing P/E Ratio: 42.52
Forward P/E Ratio: 31.72
P/E Growth: N/A
Net Income: $229.65 million
Net Margins: 12.68%
Pretax Margin: 15.29%
Return on Equity: 17.39%
Return on Assets: 11.84%

Debt

Debt-to-Equity Ratio: 0.77
Current Ratio: 2.10
Quick Ratio: 1.28

Sales & Book Value

Annual Sales: $1.24 billion
Price / Sales: 5.98
Cash Flow: $4.70 per share
Price / Cash Flow: 30.04
Book Value: $28.00 per share
Price / Book: 5.04

Miscellaneous

Outstanding Shares: 52,530,000
Free Float: 47,435,000
Market Cap: $7.42 billion
Optionable: Optionable
Beta: 0.96

Social Links

Key Executives

Mr. Joseph E. Kiani (Age 57)
Founder, CEO & Chairman
Comp: $4.22M

Mr. Micah Young (Age 43)
Exec. VP of Fin. & CFO
Comp: $773.81k

Mr. Bilal Muhsin (Age 41)
Chief Operating Officer
Comp: $986.31k

Mr. Thomas Samuel McClenahan (Age 49)
Exec. VP, Gen. Counsel & Corp. Sec.
Comp: $774.53k

Mr. Tao Leopold Levy (Age 48)
Exec. VP of Bus. Devel.
Comp: $631.6k

Mr. Yongsam Lee (Age 57)
Exec. VP & Chief Information Officer

Dr. Steven J. Barker (Age 77)
Chairman of Scientific Advisory Board & Chief Science Officer

Mr. Eli Kammerman
VP of Bus. Devel. & Investor Relations

Mr. Jon Coleman (Age 58)
Pres of Worldwide Sales, Professional Services & Medical Affairs

Mr. Anand Sampath (Age 56)
Exec. VP of Operations & Clinical Research

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MASI Stock - Frequently Asked Questions

Should I buy or sell Masimo stock right now?: 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MASI shares.
View MASI analyst ratings or view top-rated stocks.
What is Masimo's stock price forecast for 2022?: 7 Wall Street analysts have issued 12-month target prices for Masimo's stock. Their MASI share price forecasts range from $150.00 to $295.00. On average, they expect the company's share price to reach $194.50 in the next year. This suggests a possible upside of 37.8% from the stock's current price.
View analysts price targets for MASI or view top-rated stocks among Wall Street analysts.
How have MASI shares performed in 2022?: Masimo's stock was trading at $292.78 at the beginning of the year. Since then, MASI stock has decreased by 51.8% and is now trading at $141.16.
View the best growth stocks for 2022 here.
When is Masimo's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 25th 2022.
View our MASI earnings forecast.
How were Masimo's earnings last quarter?: Masimo Co. (NASDAQ:MASI) released its quarterly earnings data on Tuesday, August, 9th. The medical equipment provider reported $1.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.16. The medical equipment provider earned $565.30 million during the quarter, compared to analysts' expectations of $540.56 million. Masimo had a trailing twelve-month return on equity of 17.39% and a net margin of 12.68%. The business's revenue for the quarter was up 87.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.94 EPS.
What guidance has Masimo issued on next quarter's earnings?: Masimo updated its third quarter 2022 earnings guidance on Tuesday, September, 13th. The company provided earnings per share guidance of $0.85-$0.97 for the period, compared to the consensus EPS estimate of $1.13. The company issued revenue guidance of $515.00 million-$545.00 million, compared to the consensus revenue estimate of $553.16 million.

What is Joe E. Kiani's approval rating as Masimo's CEO?: 136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees.
What other stocks do shareholders of Masimo own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).
What is Masimo's stock symbol?: Masimo trades on the NASDAQ under the ticker symbol "MASI."
How do I buy shares of Masimo?: Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Masimo's stock price today?: One share of MASI stock can currently be purchased for approximately $141.16.
How much money does Masimo make?: Masimo (NASDAQ:MASI) has a market capitalization of $7.42 billion and generates $1.24 billion in revenue each year. The medical equipment provider earns $229.65 million in net income (profit) each year or $3.32 on an earnings per share basis.
How many employees does Masimo have?: The company employs 6,200 workers across the globe.
How can I contact Masimo?: Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001.

This page (NASDAQ:MASI) was last updated on 10/1/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Masimo - MASI Stock Forecast, Price & News

Masimo MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows